Health
Research shows how remdesivir inhibits SARS-CoV-2 replication – News-Medical.Net
In a recent bioRxiv preprint, a research team from Germany, Goran Kokic et al. study the molecular mechanism of remdesivir-induced stalling of RdRp – using synthetic…
Amidst the frantic global search for a vaccine to inhibit SARS-CoV-2 or a drug to treat coronavirus 2019 (COVID-19), remdesivir has been recently approved by the U.S. FDA to treat COVID-19 patients.
The causative agent of COVID-19, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has exhibited a positive response to this nucleoside analog drug.
The virus uses an RNA-dependent RNA polymerase (RdRp) to replicate. The active form of remdesivir inhibits the RdRp and exhibits antiviral…
-
General21 hours agoAustralian economy still vulnerable to US bond turmoil
-
Noosa News6 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast
-
Business20 hours ago2 ASX 200 shares that could be top buys for growth
-
General7 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle